The use of statins [HMG-CoA reductase inhibitors] does not appear to be significantly associated with idiopathic polyneuropathy

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1059, 2005-01, pp. : 4-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HMG-CoA Reductase Inhibitors as Immunomodulators: Potential Use in Transplant Rejection

By Raggatt L.J.   Partridge N.C.  

Drugs, Vol. 62, Iss. 15, 2002-01 ,pp. : 2185-2191

Adis International

Access to resources Recommend Favorite

Therapeutic use of HMG-CoA reductase inhibitors: current practice and future perspectives

By Cattaneo Dario   Baldelli Sara   Merlini Simona   Zenoni Stefania   Perico Norberto   Remuzzi Giuseppe  

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 11, 2004-11 ,pp. : 1553-1566

Informa Healthcare

Access to resources Recommend Favorite

Effects of HMG-CoA Reductase Inhibitors on Skeletal Muscle: Are all Statins the Same?

By Evans M.   Rees A.  

Drug Safety, Vol. 25, Iss. 9, 2002-01 ,pp. : 649-663

Adis International

Access to resources Recommend Favorite

The Effects of HMG-CoA Reductase Inhibitors on Endothelial Function

By Tesfamariam Belay  

American Journal of Cardiovascular Drugs, Vol. 6, Iss. 2, 2006-01 ,pp. : 115-120

Adis International

Access to resources Recommend Favorite

HMG-CoA Reductase Inhibitors in the Prevention of Stroke

By van Mil A.H.M.  

Drugs, Vol. 59, Iss. 1, 2000-01 ,pp. : 1-6

Adis International

Access to resources Recommend Favorite